MARIO FERNÁNDEZ RUIZ-rekin lankidetzan egindako argitalpenak (26)

2023

  1. Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years

    GeroScience, Vol. 45, Núm. 1, pp. 543-553

  2. Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5-adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients

    Transplantation Direct, Vol. 9, Núm. 10, pp. E1536

2022

  1. Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

    International Journal of Infectious Diseases, Vol. 117, pp. 56-64

2021

  1. Circulatory follicular helper T lymphocytes associate with lower incidence of CMV infection in kidney transplant recipients

    American Journal of Transplantation, Vol. 21, Núm. 12, pp. 3946-3957

  2. Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study

    International Journal of Infectious Diseases, Vol. 105, pp. 487-494

  3. Discordance Between SARS-CoV-2-specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients

    Transplantation Direct, Vol. 7, Núm. 12, pp. E794

  4. Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study

    International Journal of Infectious Diseases, Vol. 105, pp. 319-325

  5. IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 5, pp. 1652-1661.e1

  6. SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy

    Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 6, pp. 1258-1262

  7. T cell–mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19

    American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2785-2794

2020

  1. Early Posttransplant Mobilization of Monocytic Myeloid-derived Suppressor Cell Correlates With Increase in Soluble Immunosuppressive Factors and Predicts Cancer in Kidney Recipients

    Transplantation, Vol. 104, Núm. 12, pp. 2599-2608

  2. IL-6–based mortality risk model for hospitalized patients with COVID-19

    Journal of Allergy and Clinical Immunology, Vol. 146, Núm. 4, pp. 799-807.e9

2018

  1. Post-transplant hypocomplementemia: A novel marker of cardiovascular risk in kidney transplant recipients?

    Atherosclerosis, Vol. 269, pp. 204-210

2017

  1. Complement C3F allotype synthesized by liver recipient modifies transplantation outcome independently from donor hepatic C3

    Clinical Transplantation, Vol. 31, Núm. 1

2016

  1. Immune risk phenotype in kidney transplant recipients: a reliable surrogate for premature immune senescence and increased susceptibility to infection?

    Transplant Infectious Disease

  2. Low natural killer cell counts and onset of invasive fungal disease after solid organ transplantation

    Journal of Infectious Diseases

  3. Monitoring of intracellular adenosine triphosphate in CD4+ T cells to predict the occurrence of cytomegalovirus disease in kidney transplant recipients

    Transplant International, Vol. 29, Núm. 10, pp. 1094-1105

  4. Post-transplant monitoring of NK cell counts as a simple approach to predict the occurrence of opportunistic infection in liver transplant recipients

    Transplant Infectious Disease, Vol. 18, Núm. 4, pp. 552-565

2015

  1. Potential role of post-transplant hypogammaglobulinemia in the risk of Clostridium difficile infection after kidney transplantation: a case–control study

    Infection, Vol. 43, Núm. 4, pp. 413-422

2014

  1. Assessing the risk of de novo malignancy in kidney transplant recipients: Role for monitoring of peripheral blood lymphocyte populations

    Transplantation